Pages that link to "Q38768392"
Jump to navigation
Jump to search
The following pages link to Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies. (Q38768392):
Displaying 50 items.
- Novel T cells with improved in vivo anti-tumor activity generated by RNA electroporation (Q33874986) (← links)
- Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells (Q37474007) (← links)
- Chimeric antigen receptor T-cell therapies for lymphoma (Q38600697) (← links)
- Automated enrichment, transduction and expansion of clinical-scale CD62L+ T cells for manufacturing of GTMPs (Q38827775) (← links)
- The promise of chimeric antigen receptor T cells (CARTs) in leukaemia (Q39039017) (← links)
- T memory stem cells in health and disease. (Q39070577) (← links)
- Curtailed T-cell activation curbs effector differentiation and generates CD8+ T cells with a naturally-occurring memory stem cell phenotype (Q40149591) (← links)
- Therapeutic T cell engineering (Q40199809) (← links)
- Notch-mediated conversion of activated T cells into stem cell memory-like T cells for adoptive immunotherapy. (Q41993883) (← links)
- CD28 and 41BB Costimulation Enhances the Effector Function of CD19-Specific Engager T Cells (Q45870963) (← links)
- C-MPL provides tumor-targeted T cell receptor-transgenic T cells with co-stimulation and cytokine signals (Q45873673) (← links)
- Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy (Q45875529) (← links)
- Wnt pathway activator TWS119 enhances the proliferation and cytolytic activity of human γδT cells against colon cancer (Q47440172) (← links)
- The Evolution and Future of CAR T Cells for B-Cell Acute Lymphoblastic Leukemia. (Q47820469) (← links)
- A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects. (Q48106124) (← links)
- Allogeneic cell therapy manufacturing: process development technologies and facility design options (Q50432799) (← links)
- PI3K orchestration of the in vivo persistence of chimeric antigen receptor-modified T cells (Q50534706) (← links)
- CAR T-cell therapy for glioblastoma: ready for the next round of clinical testing? (Q52658445) (← links)
- Generation and application of human induced-stem cell memory T (iTSCM ) cells for adoptive immunotherapy. (Q54201515) (← links)
- Effects of Glycogen Synthase Kinase-3β Inhibitor TWS119 on Proliferation and Cytokine Production of TILs From Human Lung Cancer. (Q54976815) (← links)
- Adoptive Transfer of Interleukin-21-stimulated Human CD8+ T Memory Stem Cells Efficiently Inhibits Tumor Growth. (Q54977185) (← links)
- CAR T Cells with Enhanced Sensitivity to B Cell Maturation Antigen for the Targeting of B Cell Non-Hodgkin's Lymphoma and Multiple Myeloma (Q56966447) (← links)
- AKT-inhibition facilitates generation of polyfunctional stem cell memory-like CD8 T cells for adoptive immunotherapy (Q57135104) (← links)
- Characterization of clinical grade CD19 chimeric antigen receptor T cells produced using automated CliniMACS Prodigy system (Q57482923) (← links)
- Switchable control over in vivo CAR T expansion, B cell depletion, and induction of memory (Q58106930) (← links)
- Engineering CAR-T Cells for Improved Function Against Solid Tumors (Q58694793) (← links)
- Antioxidant metabolism regulates CD8+ T memory stem cell formation and antitumor immunity (Q58883571) (← links)
- Antigen-specific CD8+ memory stem T cells generated from human peripheral blood effectively eradicate allogeneic targets in mice (Q59790777) (← links)
- Biomaterial-Based Activation and Expansion of Tumor-Specific T Cells (Q64067972) (← links)
- Memory T Cells in Pregnancy (Q64084501) (← links)
- Fueling Cancer Immunotherapy With Common Gamma Chain Cytokines (Q64230023) (← links)
- Virus-Specific T Cells: Current and Future Use in Primary Immunodeficiency Disorders (Q64375296) (← links)
- Immunological history governs human stem cell memory CD4 heterogeneity via the Wnt signaling pathway (Q89636889) (← links)
- Lactate dehydrogenase inhibition synergizes with IL-21 to promote CD8+ T cell stemness and antitumor immunity (Q89983072) (← links)
- Obesity and CD8 T cell metabolism: Implications for anti-tumor immunity and cancer immunotherapy outcomes (Q90212537) (← links)
- CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies (Q90287452) (← links)
- Simultaneous Deletion of Endogenous TCRαβ for TCR Gene Therapy Creates an Improved and Safe Cellular Therapeutic (Q90855852) (← links)
- Autologous CD19-directed chimeric antigen receptor-T cell is an effective and safe treatment to refractory or relapsed diffuse large B-cell lymphoma (Q90950080) (← links)
- Proliferation tracing with single-cell mass cytometry optimizes generation of stem cell memory-like T cells (Q91451508) (← links)
- The transcription factor c-Myb regulates CD8+ T cell stemness and antitumor immunity (Q91692140) (← links)
- A long way to the battlefront: CAR T cell therapy against solid cancers (Q91756506) (← links)
- Wnt canonical pathway activator TWS119 drives microglial anti-inflammatory activation and facilitates neurological recovery following experimental stroke (Q91763488) (← links)
- Oncolytic Viruses: Priming Time for Cancer Immunotherapy (Q92010591) (← links)
- Engineering strategies to overcome the current roadblocks in CAR T cell therapy (Q92059900) (← links)
- Mechanisms of resistance to CAR T cell therapy (Q92150199) (← links)
- T cell receptor-based cancer immunotherapy: Emerging efficacy and pathways of resistance (Q92245345) (← links)
- IL-21 Expands HIV-1-Specific CD8+ T Memory Stem Cells to Suppress HIV-1 Replication In Vitro (Q92646814) (← links)
- The role of allogeneic HSCT after CAR T cells for acute lymphoblastic leukemia (Q92735548) (← links)
- Traceless aptamer-mediated isolation of CD8+ T cells for chimeric antigen receptor T-cell therapy (Q92826593) (← links)
- Advances and Challenges of CAR T Cells in Clinical Trials (Q93039755) (← links)